Restoring long‐lasting midface volume in the Asian face with a hyaluronic acid filler: A randomized controlled multicenter study
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16221 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Rongxin Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Dermal Fillers, Asian People, Face. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Galderma.
Abstract (Originalsprache)
Background
Hyaluronic acid (HA) filler treatment is a minimally‐invasive alternative to surgery to volumize the cheeks. HA VOL (Restylane ® Volyme) is a flexible HA filler suited to contouring and volumizing the midface.
Methods
This randomized, evaluator‐blinded, no‐treatment controlled study evaluated effectiveness and safety of HA VOL for correction of midface volume deficit and midface contour deficiency in Chinese subjects. In total 111 subjects were randomized to HA VOL and 37 to no treatment (control). The primary endpoint was response, on the blinded evaluator‐assessed Medicis Midface Volume Scale (MMVS), at 6 months after last injection for the treatment group and 6 months after randomization for controls, where response was defined as ≥1‐point improvement from baseline on both sides of the face.
Results
HA VOL was superior to no treatment at 6 months, meeting the primary objective: 76% versus 8% MMVS responders, a difference of 68% (CI: 55.7%–79.4%, p < 0.0001). These effects were sustained in 51% at 12 months after last injection. A majority (≥96%) had improved aesthetic appearance of midface fullness at Month 1 (using the Global Aesthetic Improvement Scale [GAIS]), effects which remained in ≥80% up to 12 months. Volume change captured by 3D photography increased after 1 month to 3.6 mL (close to the total injected volume of 3.4 mL), and remained stable through 12 months. Over 97% reported satisfaction with results after treatment with HA VOL . Additionally, HA VOL was well tolerated, with no unanticipated related adverse events.
Conclusions
This study showed that HA VOL is effective and well tolerated for midface treatment in a Chinese population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- Peking University 3rd Hospital, Beijing, China.
- China Japan Friendship Hospital, Beijing, China.
- West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
- Yantai Yuhuangding Hospital, Yantai, Shandong, China.
- Galderma Aesthetics, Uppsala, Sweden.
ORCID-Profile: Hongyi Zhao
Förderung
- Galderma
Zitieren
APA
Ren, R., Xue, H., Gao, Z., Wang, H., Xia, X., Qu, Y., Bromée, T., Almegård, B., & Zhao, H. (2024). Restoring long‐lasting midface volume in the Asian face with a hyaluronic acid filler: A randomized controlled multicenter study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16221
Vancouver
Ren R, Xue H, Gao Z, Wang H, Xia X, Qu Y, et al. Restoring long‐lasting midface volume in the Asian face with a hyaluronic acid filler: A randomized controlled multicenter study. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16221
BibTeX
@article{Ren2024,
author = {Ren, Rongxin and Xue, Hongyu and Gao, Zhanwei and Wang, Hang and Xia, Xiujuan and Qu, Yan and Bromée, Torun and Almegård, Birgitta and Zhao, Hongyi},
title = {Restoring long‐lasting midface volume in the Asian face with a hyaluronic acid filler: A randomized controlled multicenter study},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16221}
}
EUVIMED